# PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease

Source: https://onco.cc/trials/nct07069595/  
OnCo record `nct07069595` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of datopotamab deruxtecan in triple-negative breast cancer, run by UNC Lineberger Comprehensive Cancer Center, now recruiting.

## Summary

PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease. ClinicalTrials.gov record last updated 2026-04-22: recruiting. Enrollment is planned at 78 participants. Primary completion is estimated at 2031-11-01. No tabular results are posted on ClinicalTrials.gov; this does not exclude separate publications. Registered interventions: Datopotamab deruxtecan, Circulating tumor DNA (ctDNA) testing. Registered primary measures: The proportion of triple negative breast cancer (TNBC) with molecular residual disease (MRD).

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-10-06
- Also known as: PREDICT-RD
- Tags: ctgov-ingest; tnbc-deep-dive
- Registry id: NCT07069595
- Phase: 2
- Setting: PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease
- Sponsor: UNC Lineberger Comprehensive Cancer Center
- Enrolled: 78

## Notes

- ClinicalTrials.gov record last updated 2026-04-22: recruiting. Enrollment is planned at 78 participants. Primary completion is estimated at 2031-11-01. No tabular results are posted on ClinicalTrials.gov; this does not exclude separate publications.

## Sources

- ClinicalTrials.gov NCT07069595: https://clinicaltrials.gov/study/NCT07069595

## Connected records

- cancers: [Early triple-negative breast cancer](https://onco.cc/cancers/tnbc-early/)
- technologies: [Antibody-drug conjugate (ADC)](https://onco.cc/technologies/adc/)
- targets: [TROP2](https://onco.cc/targets/trop2/)
- drugs: [Datopotamab deruxtecan](https://onco.cc/drugs/datopotamab-deruxtecan/)
- terms: [Triple-negative breast cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/tnbc-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct07069595.json